002107.SZ
Shandong Wohua Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.88
+1.20%Year over year
Reported trailing growth
- Revenue
- -1.1%
- EBITDA
- —
- EBIT
- +78.1%
- EPS
- +67.6%
- Free cash flow
- +20.5%
- Operating cash flow
- +19.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -7.0%
- EBITDA
- -3.1%
- EBIT
- -2.7%
- Net income
- -3.8%
- EPS
- -3.6%
- Free cash flow
- -10.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026